Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion

Neuropsychopharmacology

Volumn 24, Issue 2, 2001, Pages 152-160

  Gracy, K Noelle ^a   Dankiewicz, Lois A ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Conditioned place aversion; Extended amygdala; Fos; Immunocytochemistry; Opiate; Withdrawal

Indexed keywords

MORPHINE; NALOXONE; OPIATE; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DRUG WITHDRAWAL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMALS; CONDITIONING (PSYCHOLOGY); MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0035204459     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00186-X     Document Type: Article

References (38)

1. Amygdala and Extended Amygdala
2. New perspectives in basal forebrain organization of special relevance for neurospychiatric disorders; The striatopallidal, amygdaloid and corticopetal components of substantia innominata
3. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal
4. Immediate early gene expression during morphine withdrawal
5. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats
6. Locomotor activity in morphine-dependent and post-dependent rats
7. Increased fos-like immunoreactivity in the periawueductal gray of anaesthetised rats during opiate withdrawal
8. Amygdala
9. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
10. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats
11. Distinct distribution of mu, delta, and kappa opioid receptor mRNA in rat brain
12. Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates
13. Aversive properties of opiate receptor blockade; Evidence for exclusively central mediation in naive and morphine-dependent rats
14. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of the rat brain
15. The accumbens; beyond the core-shell dichotomy
16. Substantia innominata; A notion which impedes clinical-anatomical correlations in neuropsychoatric disorders
17. Suppression of corticotropin releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal
18. Clinical procedures for the assessment of abuse potential
19. Antagonist-precipitated opioid withdrawal in rats; Evidence for dissociations between physical and motivational signs
20. Immunohistochemical localization of mu-opioid receptors in rat brain using antibodies generated against a peptide sequence present in a purified mu-opioid binding protein
21. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques; A comperison between ABC and unlabeled antibody (PAP) procedures
22. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal
23. Drug addiction and abuse
24. Opponent process and drug dependence; neurobiological mechanisms
25. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal
26. Role of different brain structures in the expression of the physical morphine withdrawal syndrome
27. Tolerance to and physical dependence on morphine in rats
28. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat
29. The effect of single and repeated morphine administration on the prodynorphin system activity in the nucleus accumbens and striatum of the rat
30. NMDA antagonists and clonidine block c-Fos expression during morphine withdrawal
31. Spinal cord mechanisms of opioid tolerance and dependence; Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal
32. Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal
33. Relative sensitivity to naloxone of multiple indices of opiate withdrawal; A quantitative dose-response analysis
34. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
35. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats
36. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat
37. Application of the pellet implantation technique for the assessment of tolerance and physical dependence in the rodent